Regenxbio Inc (NASDAQ:RGNX) price on Friday, June 13, fall -9.12% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $9.27.
A look at the stock’s price movement, the close in the last trading session was $10.20. Turning to its 52-week performance, $15.36 and $5.03 were the 52-week high and 52-week low respectively. Overall, RGNX moved 11.28% over the past month.
Regenxbio Inc’s market cap currently stands at around $464.99 million, with investors looking forward to this quarter’s earnings report slated for in July.
6 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 6 recommend RGNX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
RGNX’s current price about -2.86% and 10.34% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 50.26, while 7-day volatility ratio is 6.14% and 7.75% in the 30-day chart. Further, Regenxbio Inc (RGNX) has a beta value of 1.10, and an average true range (ATR) of 0.94. Analysts have given the company’s stock an average 52-week price target of $27, forecast between a low of $24 and high of $30. Looking at the price targets, the low is -158.9% off current price level while to achieve the yearly target high, price needs to move -223.62%. Nonetheless, investors will most likely welcome a -191.26% jump to $27 which is the analysts’ median price.
If we refocus on Regenxbio Inc (NASDAQ:RGNX), historical trading data shows that trading volumes averaged 1.18 million over the past 3 months. The company’s latest data on shares outstanding shows there are 50.12 million shares.
The 9.39% of Regenxbio Inc’s shares are in the hands of company insiders while institutional holders own 87.56% of the company’s shares. Current price change has pushed the stock 19.92% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the RGNX stock continues to rise going into the next quarter.
